Are you John G. Devlin, M.D.? This profile is yours to edit: update your address, phone, photo and services.
Edit this profileAt a glance
- 825 Old Lancaster Rd Ste 440, Bryn Mawr, PA 19010
About Dr. Devlin
Based in Bryn Mawr, PA, John G. Devlin, M.D. is listed in the NPI registry under hematology. John graduated from Temple University School of Medicine in 2001. John is also listed as specializing in hematology & oncology. Medicare claims data shows John provided 185,735 services to 1,301 patients. The services billed most often include injection, darbepoetin alfa, 1 microgram (non-esrd use), injection, ferric carboxymaltose, 1 mg, and injection, fosaprepitant, 1 mg. NPI 1073728663 identifies this record in the national registry.
Factual summary compiled by Guide.md from public records; not written by this provider.
Education & Training
Specialty
Credentials & Licensing
Medicare information
Exactly as CMS reports it (National Downloadable File, Opt-Out Affidavits, Order & Referring). Not an insurance directory; confirm coverage with the office.
Contact Information
- (610) 525-4511
- Email not available
Practice Locations
825 OLD LANCASTER RD STE 440
Bryn Mawr, PA 19010
Conditions Commonly Evaluated or Treated
Within Hematology generally. Availability varies by clinician, training and location — this profile has not been claimed, so nothing here is a personal claim by the provider.
Conditions
Most searched conditions
- Anemia
- Blood clots
- Breast cancer
- Colon cancer
- Iron-deficiency anemia
- Leukemia
- Lung cancer
- Lymphoma
- Prostate cancer
Anemia
- Folate Deficiency
Bleeding disorders
- Bleeding Disorders
- Frequent Unexplained Nosebleeds
- Heavy Period Bleeding From Bleeding Disorder
- Unexplained Bruising
Blood and immune disorders
- Cold Protein In Blood
- Mast Cell Activation Syndrome
Blood cancer
- Multiple Myeloma
- Pre-Myeloma Protein In Blood
- Waldenstrom Macroglobulinemia
Blood clots
- Blood Clot in Lung
- Blood Clots In Pregnancy
- Deep vein thrombosis
Bone marrow disorders
- Bone Marrow Scarring
- Myelodysplastic Syndrome
Clotting disorders
Inherited blood disorders
- Sickle Cell Trait
Iron disorders
- Hemochromatosis
- High Ferritin
- Low Ferritin
Lymph conditions
Lymph disorders
- Castleman Disease
Metabolic blood disorders
- Porphyria
Nutritional blood disorders
- Vitamin B12 deficiency
Organ conditions
Platelet disorders
- High Platelet Count
- Low Platelets
- Rare Blood Clotting Disease
Protein disorders
- Amyloidosis
Red blood cell disorders
- Cold-Triggered Blood Breakdown
- Hemolytic Anemia in Children
- Nighttime Red Blood Cell Breakdown
- Sickle cell disease
- Thalassemia
- Thick Blood
White blood cell disorders
- High Eosinophil Count
- High White Blood Cell Count
- Histamine Intolerance
- Low White Blood Cell Count
Procedures & services
Most searched procedures
- Blood transfusion
- Chemotherapy
- Immunotherapy
- Targeted therapy
Biopsy
- Bone Marrow Biopsy
Blood treatments
- Blood Exchange Transfusion
- Plasmapheresis
- Platelet Removal Procedure
- Therapeutic Blood Draw
- White Blood Cell Removal Procedure
Catheter care
- Chemo Port Flush And Maintenance
Cell therapy
- Donor Lymphocyte Infusion
Cellular therapy
- CAR-T Therapy
Consultation
- Bleeding Disorder Testing
- Second Opinion For Blood Disorders
Consultations
- Port Placement Consultation
- Pre-Surgery Bleeding Clearance
Diagnostic tests
- Clotting Inhibitor Mixing Study
- Complete Blood Count
- Factor Level Blood Test
- Folic Acid Blood Test
- G6PD Enzyme Test
- Iron Level Blood Test
Infusions
- Clotting Factor Replacement
- Iron Infusion
- IVIG Infusion
Injections
- Red Blood Cell Booster Shots
- White Blood Cell Booster Injection
Lab tests
- Blood Cancer Cell Marker Test
- Blood Clotting Tests
- Blood Smear Examination
- Coomb's Test
- Genetic Blood Clotting Test
- Hemoglobin Electrophoresis
- Myeloma Blood Protein Test
Medication management
- Blood Clot Management
- Iron Chelation Therapy
Monitoring
- Coumadin INR fingerstick test
Patient education
- Clotting Factor Self-Infusion Training
Procedures
- Apheresis for Children
- Bone Marrow Harvest
- Port Removal Procedure
Transfusion therapy
- Blood Transfusion Management
- Platelet Transfusion
Transplants
- Stem Cell Donor Matching
- Stem Cell Transplant
Treatments
- Desmopressin Treatment
- Sickle Cell Crisis Treatment
Procedures Most Often Billed to Medicare
185,735 services · 1,301 patients · 25 distinct codes
| Procedure | Type | Code | Services | Compared with peers |
|---|---|---|---|---|
| Insertion of needle into vein for collection of blood sample | Procedure | 36415 |
1,048 | More often than most peers in Hematology |
| Injection of additional new drug or substance into vein | Treatment | 96375 |
2,482 | More than most peers in Hematology |
| Administration of chemotherapy into vein, 1 hour or less | Treatment | 96413 |
782 | More than most peers in Hematology |
| Injection of drug or substance under skin or into muscle | Treatment | 96372 |
689 | More than most peers in Hematology |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Treatment | 96367 |
242 | More often than most peers in Hematology |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Drug given | J0881 |
59,700 | More than most peers in Hematology |
| Injection, ferric carboxymaltose, 1 mg | Drug given | J1439 |
32,253 | As often as other peers in Hematology |
| Injection, fosaprepitant, 1 mg | Drug given | J1453 |
22,800 | More than most peers in Hematology |
| Injection, paclitaxel protein-bound particles, 1 mg | Drug given | J9264 |
21,170 | More than most peers in Hematology |
| Injection, pembrolizumab, 1 mg | Drug given | J9271 |
19,200 | More often than most peers in Hematology |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
Related providers
Connections drawn from the registry and from what providers have told us. A link here is not a referral or an endorsement.
Related specialists at this location 2
Clinically related specialties at the same address — the people this provider most likely works alongside.
Also at this address 4
Providers at the same street address. Each files their own registry entry, so a shared practice often appears under several different names.
More connections — 18 related providers in 3 groups
Trained at Temple University School of Medicine 6
Other providers in the same specialty who trained at the same institution.
Class of 2001 at Temple University School of Medicine 8
Providers who graduated from the same medical school in the same year.
Also performs Insertion of needle into vein for collection of blood sample 4
Providers in PA who bill this service to Medicare most often.
Common questions
What does John G. Devlin specialize in?
John G. Devlin is a hematology in Bryn Mawr, PA. That is the designation recorded for this NPI in the federal registry.
NPI registry
Where is John G. Devlin located?
John G. Devlin is listed at 825 Old Lancaster Rd Ste 440, Bryn Mawr, PA 19010. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
What is John G. Devlin's phone number?
The number on file is (610) 525-4511. Contact the office directly to confirm availability and scheduling.
NPI registry
What is the NPI for John G. Devlin?
John G. Devlin's National Provider Identifier is 1073728663. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
Where did John G. Devlin train?
John G. Devlin attended Temple University School of Medicine, graduating in 2001. This comes from the CMS National Downloadable File.
CMS public data
How much experience does John G. Devlin have?
John G. Devlin has 25 years experience. Calculated from a graduation year of 2001, reported in the CMS National Downloadable File.
CMS public data
What does John G. Devlin do most often?
According to Medicare billing data, John G. Devlin performs procedures including insertion of needle into vein for collection of blood sample; provides treatments such as injection of additional new drug or substance into vein and administration of chemotherapy into vein, 1 hour or less, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Is John G. Devlin's profile verified?
Not yet. This profile is built from public federal data and has not been confirmed by John G. Devlin. If this is you, claiming it is free.
Guide.md
Guide.md listings do not constitute medical advice or an endorsement.